Novavax says its COVID-19 shot is on track for full FDA approval

News

FDA will limit approval for seasonal COVID vaccines

FDA to limit covid shot approval to 65+, those with medical conditions

The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.

Associated Press News · 29d

Novavax says its COVID-19 shot is on track for full FDA approval after delay

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the Food and Drug Administration.

Reuters on MSN · 3d

FDA approves Novavax COVID vaccine with new conditions

The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness. The vaccine's prospects were thrown into doubt after the FDA missed its April 1 target to approve the shot,

MedPage Today29d

Novavax Says Its COVID Shot Is on Track for Full FDA Approval After Delay

Novavax's closely watched COVID-19 vaccine is on track for full approval ... about vaccine safety. With full FDA approval, Novavax would have permission to keep its shot on the ...

Novavax Shares Rise on FDA License Application Approval for Nuvaxovid

Shares rose 10% to $7.41 in premarket trading on Monday. The stock is down 21% on the year. The biotechnology company said the FDA approved the biologics license application for Nuvaxovid to prevent ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending on Bing

News

FDA will limit approval for seasonal COVID vaccines